<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02485392</url>
  </required_header>
  <id_info>
    <org_study_id>KEK-ZH 2014-0114</org_study_id>
    <nct_id>NCT02485392</nct_id>
  </id_info>
  <brief_title>A Comparison of Robot-assisted Single Site and Laparoscopic Single-incision Cholecystectomy for Benign Gallbladder</brief_title>
  <official_title>A Comparison of Robot-assisted Single Site and Laparoscopic Single-incision Cholecystectomy for Benign Gallbladder</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kantonsspital Winterthur KSW</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kantonsspital Winterthur KSW</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A single-blinded randomized clinical trial (RCT) designed to compare Single-Site&#xD;
      robot-assisted with single-incision laparoscopic cholecystectomy. The study directly compares&#xD;
      both surgical approaches in a cohort of 60 patients (30 patients in each arm) with benign&#xD;
      gallbladder disease from the Department of Surgery at the Cantonal Hospital of Winterthur&#xD;
      (Kantonsspital Winterthur) in Switzerland. The primary endpoint of the study is the surgeon's&#xD;
      physical and mental stress load at the time of surgery and is assessed by validated Local&#xD;
      Experienced Discomfort (LED) and Subjective Mental Effort Questionnaire (SMEQ) visual&#xD;
      analogue scales. The secondary endpoints include costs of the procedure, intra-operative&#xD;
      blood loss, operating time, intra-operative conversion rate and additional trocar placement,&#xD;
      complications, length of hospital stay, Health-Related Quality of Life (HRQoL) and cosmesis.&#xD;
      HRQoL and cosmesis will be assessed using the validated Gastrointestinal Quality of Life&#xD;
      Index (GIQLI) and the Body Image Questionnaires (BIQ), respectively. The inclusion criteria&#xD;
      cover most notably symptomatic cholecystolithiasis, chronic cholecystitis, benign gallbladder&#xD;
      polyps and age ≥18 years. The exclusion criteria are, among others, acute cholecystitis,&#xD;
      emergency cholecystectomy, previous extensive upper abdominal surgery and suspicion of&#xD;
      malignant disease. Non-stratified block randomization (random block sizes 2 and 4) will be&#xD;
      used to achieve balance in the allocation of participants to both treatments arms and prevent&#xD;
      a premature decoding of the randomization scheme. Hereby, the patient will not be informed&#xD;
      about the group assignment until the last outpatient follow-up and only after he/she has&#xD;
      completed and returned all required questionnaires (GIQLI and BIQ). The operation will be&#xD;
      performed according to the group assignment by senior surgeons only who have a wide&#xD;
      experience in both robotic Single-Site and conventional single-incision laparoscopy. All data&#xD;
      are recorded safely using the SecuTrialTM program. Sample-size calculations are based on the&#xD;
      results of the previously mentioned experimental setup by Schatte et al, utilizing an&#xD;
      estimated effect size of 0.8, at a power of 0.8 and an alpha-error level of 0.05, as well as&#xD;
      considering a potential additional error margin of 10-15% of the calculations (G-Power 3.1&#xD;
      software, Heinrich-Heine University Duesseldorf/Germany). The estimated total duration of the&#xD;
      study is 1.5 years, including the scheduled 1-month and 1-year postoperative follow-up&#xD;
      visits. The study will be carried out in accordance with principles enunciated in the current&#xD;
      version of the Declaration of Helsinki, the guidelines of Good Clinical Practice (GCP) issued&#xD;
      by International Conference on Harmonization (ICH), and Swiss regulatory authority's&#xD;
      requirements.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>July 2015</start_date>
  <completion_date type="Anticipated">July 2017</completion_date>
  <primary_completion_date type="Actual">July 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Surgeon's comfort as measured by LED and SMEQ questionnaires</measure>
    <time_frame>1 Day</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Intra-operative blood loss</measure>
    <time_frame>1 day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Operating time</measure>
    <time_frame>1 day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intra--operative conversion rate</measure>
    <time_frame>1 day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complications</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of hospital stay</measure>
    <time_frame>until discharge (average of 2 days)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Costs of procedure</measure>
    <time_frame>until discharge (average of 2 days)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health--Related Quality of Life (HRQoL)</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cosmesis as measured by Body Image Questionnaire (BIQ)</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intra-operative additional trocar placement</measure>
    <time_frame>1 day</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Benign Gallbladder Disease</condition>
  <arm_group>
    <arm_group_label>Single-Site robot-assisted cholecystectomy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Single-Site robot-assisted cholecystectomy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Single-incision laparoscopic cholecystectomy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Single-incision laparoscopic cholecystectomy</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Da Vinci Single Site Robot-Assisted Cholecystectomy</intervention_name>
    <arm_group_label>Single-Site robot-assisted cholecystectomy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Single Incision Laparoscopic Cholecystectomy</intervention_name>
    <arm_group_label>Single-incision laparoscopic cholecystectomy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient compliance and geographic proximity allow proper preoperative checkup and&#xD;
             postoperative follow-up&#xD;
&#xD;
          -  Written informed consent given by the patient&#xD;
&#xD;
          -  Women who are not breastfeeding and are not pregnant&#xD;
&#xD;
          -  Age ≥18 years&#xD;
&#xD;
          -  Symptomatic cholecystolithiasis&#xD;
&#xD;
          -  Chronic cholecystitis&#xD;
&#xD;
          -  Benign gallbladder polyps&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Significant concomitant diseases making the patient unsuitable for abdominal surgery&#xD;
             by the judgement of the physicians involved&#xD;
&#xD;
          -  Peritoneal carcinomatosis or other extensive metastatic disease&#xD;
&#xD;
          -  American Society of Anesthesiologists (ASA) IV and V patients&#xD;
&#xD;
          -  Mental or organic disorders which could interfere with giving informed consent or&#xD;
             receiving treatments&#xD;
&#xD;
          -  Contraindications to pneumoperitoneum&#xD;
&#xD;
          -  Suspicion of malignant disease&#xD;
&#xD;
          -  Previous extensive upper abdominal surgery&#xD;
&#xD;
          -  Acute cholecystitis&#xD;
&#xD;
          -  Emergency cholecystectomy&#xD;
&#xD;
          -  Obesity II°---III° (BMI&gt;35.0 kg/m2)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stefan Breitenstein, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kantonsspital Winterthur KSW</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Kantonsspital Winterthur</name>
      <address>
        <city>Winterthur</city>
        <zip>8401</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>September 2016</verification_date>
  <study_first_submitted>February 19, 2015</study_first_submitted>
  <study_first_submitted_qc>June 25, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 30, 2015</study_first_posted>
  <last_update_submitted>September 8, 2016</last_update_submitted>
  <last_update_submitted_qc>September 8, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 9, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gallbladder Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

